Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Results 71 - 80 of 111 for ShangPharma. (0.07 seconds)

Beijing announced a 10 billion RMB ($1.5 billion) fund to...
In a surprising move, Eli Lilly said it will close its...
Eli Lilly will build a bricks and mortar center dedicated...
For the first time in 29 years, the industry's most...
It's earnings season, and almost every day for the past...
Pharmaron, China’s third-largest CRO, announced a...
Simcere Pharma, like many US-listed China biopharmas, has...
Dr. Arthur Taveras, President and CSO of ChemPartner,...
Shanghai ChemPartner, a CRO/CMO, has closed its reverse...
The Keynote Panel from the recently...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here